Are your decisions to delay treatment intensification clinical inertia or “appropriate inaction?” Is obesity management a primary treatment goal for your patients with T2DM? Assess how effective you are in achieving short- and long-term therapeutic goals for your patients through this clinical assessment tool and walk away with personalized recommendations and education to address inertia through weight-centric treatment strategies.
Not interested in the assessment? Check out this companion CME activity where these expert faculty share best practices for managing patients with dysglycemia and obesity.
Sponsored by the Academy for Continued Healthcare Learning.
Supported by an educational grant from Lilly.
Laurie Novoryta
Lnovoryta@achlcme.org